Relevance of Tissue Factor and Tissue Factor Pathway Inhibitor for Hypercoagulable State in the Lungs of Patients with Idiopathic Pulmonary Fibrosis

Author： Fujii M. Hayakawa H. Urano T. Sato A. Chida K. Nakamura H. Takada A.

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.99, Iss.2, 2000-07, pp. : 111-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tissue Factor Pathway Inhibitor Endocytosis

By Schwartz A.L. Broze G.J.

Trends in Cardiovascular Medicine, Vol. 7, Iss. 7, 1997-10 ,pp. : 234-239

Elsevier

Access to resources Recommend Favorite

TISSUE INHIBITOR OF METALLOPROTEINASE-3 IS UP-REGULATED BY TRANSFORMING GROWTH FACTOR-β1 IN VITRO AND EXPRESSED IN FIBROBLASTIC FOCI IN VIVO IN IDIOPATHIC PULMONARY FIBROSIS

By García-Alvarez Jorge Ramirez Remedios Checa Marco Nuttall Robert Sampieri Clara Edwards Dylan Selman Moisés Pardo Annie

Experimental Lung Research, Vol. 32, Iss. 5, 2006-07 ,pp. : 201-214

Informa Healthcare

Access to resources Recommend Favorite

Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis

By Cella G. Vianello A. Rampin E. Sbarai A. Boeri G. Vertolli U. Naso A. Strauss W.E.

Thrombosis Research, Vol. 81, Iss. 6, 1996-03 ,pp. : 671-677

Elsevier

Access to resources Recommend Favorite

Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients

By Gando S. Kameue T. Matsuda N. Hayakawa M. Morimoto Y. Ishitani T. Kemmotsu O.

Thrombosis Research, Vol. 109, Iss. 2, 2003-01 ,pp. : 119-124

Elsevier

Access to resources Recommend Favorite

Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism

By Erem Cihangir

Endocrine Journal, Vol. 35, Iss. 1, 2009-02 ,pp. : 75-80

Humana Press, Inc

Access to resources Recommend Favorite